Viewing Study NCT03780257

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-01-11 @ 6:09 AM
Study NCT ID: NCT03780257
Status: COMPLETED
Last Update Posted: 2022-04-20
First Post: 2018-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene
Sponsor: ProQR Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinitis Pigmentosa View
None Usher Syndrome Type 2 View
None Deaf Blind View
None Retinal Disease View
None Eye Diseases View
None Eye Diseases, Hereditary View
None Eye Disorders Congenital View
None Vision Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Retinitis Pigmentosa View
None USH2A View
None RP View
None exon 13 View
None RNA therapies View
None antisense oligonucleotide View
None exon skipping View
None STELLAR View
None IVT View
None mutations in exon 13 of the USH2A gene View
None NSRP View